A survey of cost, access and outcomes for cannabinoid‐based medicinal product use by Australians with endometriosis

Overview of attention for article published in Australian & New Zealand Journal of Obstetrics & Gynaecology, February 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 1 blog post.

First on the show we cover Cannasouth, the first cannabis company to list on the NZX under the ticker CBD, which has gone into…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.